Roche Holding AG Logo

Roche Holding AG (RO)

SIX

Currency in CHF
359.20
+1.20 (+0.34%)

Real-time Data

07:00 AM

Day's Range

357.00
366.40

52 wk Range

270.80
383.00

Overview - RO - Roche Holding AG

Key Statistics

Valuation

Enterprise Value

311.08B

P/E (Trailing)

‪23.20‬

P/E (Forward)

‪16.16‬

PEG Ratio

‪16.16‬

Price / Sales (TTM)

‪4.50‬

Price / Book

‪8.67‬

EV / EBITDA

‪12.98‬

Profitability

Profit Margin

‪19.60%‬

Operating Margin

‪36.20%‬

Return on Assets

‪13.50%‬

Return on Equity

‪38.10%‬

Ownership

Shares Outstanding

796.76M

Float

723.67M

Held by Insiders

‪72.31%‬

Held by Institutions

‪11.03%‬

Price stats

Beta

‪0.34‬

50-Day Avg

‪366.98‬

200-Day Avg

‪347.18‬

Dividends

Payout Ratio

‪63.93%‬

Frequency

Annual

Analyst Consensus

Hold

3 analysts

Average price target

‪CHF 367.00‬

News Teaser - RO - Roche Holding AG

News & Analysis

View all news

Market Cap - RO - Roche Holding AG

Peers - RO - Roche Holding AG

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on SIX.

Profile Summary - RO - Roche Holding AG

About

Roche Holding AG is a Swiss multinational holding company and one of the world's largest biotech firms, overseeing the operations of F. Hoffmann-La Roche AG, a leading provider of pharmaceuticals and in-vitro diagnostics. Founded in 1896 and headquartered in Basel, it drives innovation across major disease areas…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees103.24K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.